# Vaxcyte, Inc.: Form 8-K, filed Jul 15, 2026

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2026-07-15
- Accepted by EDGAR: Jul 15, 2026, 16:05 ET
- Period: 2026-07-13
- Accession: 0001649094-26-000030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000030/pcvx-20260713.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000030/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000164909426000030/pcvx-20260713.htm

Filed Jul 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001649094-26-000030. Last ingested by Listed: Nov 14, 2026, 19:29 ET. No prices; not investment advice.
